Accelerating Texas K12 Education: The Importance of Personalized Instruction for Students

The core foundation of every successful movement in cultivating change and growth is education. Former district superintendent and current Executive Director of The Texas School Alliance, Dr. Curtis Culwell, joined host J.W. Marshall to speak about educational policy, innovation, and student experience.

Dr. Culwell realizes that not every student starts at the same place; wherein the need for differential learning for students exists.

In learning from the pandemic, Dr. Culwell stated the need for the effects on learning to be critically evaluated and applied, if useful, in situations moving forward. In speaking on this topic, Dr. Culwell stated, “Necessity is the mother of invention,” which directly referenced the transitionary properties the pandemic has had on education.

While education today may “look like swiss cheese” given the gaps in learning that were and are still caused by the pandemic, technology is trying to fill this gap via accelerated learning.

Dr. Culwell recognized the impact distance learning had on different students and different families. The situation did not work for everyone, but there was a study recently published which highlighted that virtual learning improved learning in “10-20% of students.”

In this way, Dr. Culwell highlighted the fact that no one side fits all, especially when it comes to education. There are a multitude of aspects within learning environments, including social and emotional factors, which can contribute to the students’ learning process.

Dr. Culwell posed a question of the relationship between virtual learning and equity – how might this play out in the future of education? Dr. Culwell thought it might be creating an understanding on how one might use technology as a resource for building personalized learning plans for students.

One thing is for certain, what we learned from the pandemic and what we continue to learn is pertinent to the future of building life-long learners in education.

https://www.summitk12.com/

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More